Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model.
Vaccination of chinchillas with nontypeable Haemophilus influenzae (NTHi) lipooligosaccharide (LOS) conjugates protected against otitis media. Correlations between the levels of conjugate-induced LOS antibodies (Abs) in sera and middle ear fluids (MEFs) and Ab-mediated biological functions and protection were examined. Following parenteral vaccination and middle ear challenge, all vaccinated animals, but none of the controls, had high titers of anti-LOS in their sera and MEFs. There was a correlation between the levels of anti-LOS IgG + M, IgG or IgA in the sera and in the MEFs (P < 0.001). An inverse correlation was found between the level of serum IgG + M and bacterial counts and between the levels of MEF Abs and bacterial counts at the early postchallenge stage (P < 0.05). Of the 39 vaccinated animals, 44% showed complete protection against otitis media, 46% (18/39) of their sera inhibited adherence of NTHi to human epithelial cells, 49% (19/39) demonstrated bactericidal activity and 49% (19/39) showed opsonophagocytic activity. In contrast, none of the controls (19) were protected, none of their sera inhibited bacterial adherence or had bactericidal activity and only 21% showed opsonophagocytosis. Our interpretation is that vaccine-induced LOS Abs transuded into the middle ear and conferred immunity to NTHi by binding to LOS of NTHi, inhibition of NTHi adherence to epithelial cells and complement-mediated bacteriolysis (or opsonophagocytosis).
Sun
J
J
Laboratory of Immunology, National Institute on Deafness and Other Communication Disorders, Rockville, MD 20850, USA.
Chen
J
J
Cheng
Z
Z
Robbins
J B
JB
Battey
J F
JF
Gu
X X
XX
D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis* / Q000097:blood; D019138:Antibodies, Blocking / Q000097:blood; D000918:Antibody Specificity; D001770:Blood Bactericidal Activity / Q000276:immunology; D002682:Chinchilla; D015169:Colony Count, Microbial; D005122:Exudates and Transudates / Q000276:immunology / Q000382:microbiology; D018073:Haemophilus Vaccines / Q000276:immunology* / Q000627:therapeutic use; D006193:Haemophilus influenzae / Q000145:classification / Q000276:immunology*; D006801:Humans; D007106:Immune Sera / Q000032:analysis; D007132:Immunoglobulin Isotypes / Q000096:biosynthesis; D008070:Lipopolysaccharides / Q000276:immunology* / Q000627:therapeutic use; D009895:Opsonin Proteins / Q000276:immunology; D010034:Otitis Media with Effusion / Q000097:blood / Q000276:immunology* / Q000517:prevention & control; D010587:Phagocytosis / Q000276:immunology; D018074:Vaccines, Conjugate / Q000276:immunology / Q000627:therapeutic use
D000907:Antibodies, Bacterial; D019138:Antibodies, Blocking; D018073:Haemophilus Vaccines; D007106:Immune Sera; D007132:Immunoglobulin Isotypes; D008070:Lipopolysaccharides; D009895:Opsonin Proteins; D018074:Vaccines, Conjugate